OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
17.78
-0.34 (-1.88%)
Sep 17, 2025, 4:00 PM EDT - Market closed
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $330.09 million as of September 18, 2025. Its market cap has increased by 116.03% in one year.
Market Cap
330.09M
Enterprise Value
342.48M
1-Year Change
116.03%
Ranking
Category
Stock Price
$17.78
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $330.09M, an increase of 865.16%. That is a compound annual growth rate of 36.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 336.40M | 275.87% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
| Jun 22, 2018 | 34.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |